(Q38605299)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26459093%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

title

Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26459093%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26459093%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

R Dersch

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26459093%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

H Sommer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26459093%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

S Rauer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26459093%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

12 October 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26459093%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26459093%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26459093%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26459093%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

17-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26459093%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-015-7923-0

26 February 2020

exact match

0 references

cites work

Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

Risk factors for a non-favorable outcome after treated European neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

Evidence-based guidelines for the management of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

Tick-borne encephalitis carries a high risk of incomplete recovery in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

Subjective symptoms after treatment of early Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

Perspectives on "chronic Lyme disease".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

Efficacy and safety of pharmacological treatments for neuroborreliosis--protocol for a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

Multiple Comparisons among Means

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

Evaluation of study patients with Lyme disease, 10-20-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

European neuroborreliosis: quality of life 30 months after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

Lyme encephalopathy: long-term neuropsychological deficits years after acute neuroborreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7923-0

Lyme disease: an infectious and postinfectious syndrome.

21 January 2018

1 reference

12 December 2020

Incidence of Lyme borreliosis in the Würzburg region of Germany

1 reference

12 December 2020

Lyme disease: a multisystem infection that affects the nervous system

1 reference

12 December 2020

Lyme borreliosis: clinical case definitions for diagnosis and management in Europe

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

1 reference

12 December 2020